Harm potential of magic mushroom use: a review (Q34025454)

30 July 2017

1 reference

title

Harm potential of magic mushroom use: a review (English)

1 reference

30 July 2017

Jan van Amsterdam

1

1 reference

30 July 2017

Antoon Opperhuizen

series ordinal

2

1 reference

30 July 2017

Wim van den Brink

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

21 January 2011

1 reference

Regulatory Toxicology and Pharmacology

30 July 2017

1 reference

30 July 2017

59

1 reference

30 July 2017

3

1 reference

30 July 2017

423-429

1 reference

The psychopharmacology of hallucinogens

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

A private inquiry into the circumstances surrounding the 1972 death of John Gomilla, Jr., who died after allegedly consuming ten hallucinogenic mushrooms while residing in Hawaii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

An ethnomycological review of psychoactive agarics in Australia and New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Persistent psychiatric symptoms after eating psilocybin mushrooms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Mushroom Poisoning since 1924 in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Intravenous mushroom poisoning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Inhibition of monoamine oxidase B in the brains of smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Do hallucinogens cause residual neuropsychological toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Hallucinogen persisting perception disorder: what do we know after 50 years?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Cross tolerance between LSD and psilocybin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

REACTIONS TO PSILOCYBJN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Khat and mushrooms associated with psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Development of a rational scale to assess the harm of drugs of potential misuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Drug harms in the UK: a multicriteria decision analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Between prohibitions: patterns and meanings of magic mushroom use in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Who is becoming hallucinogen dependent soon after hallucinogen use starts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

A systems model of altered consciousness: integrating natural and drug-induced psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

Effects of psilocybin on time perception and temporal control of behaviour in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Intravenous injection of mushrooms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2011.01.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YRTPH.2011.01.006

1 reference

30 July 2017

1 reference